about
Laparoscopic cholecystectomy for melanoma metastatic to the gallbladder: is it an adequate surgical procedure? Report of a case and review of the literatureRole of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy.Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma.Electrochemotherapy efficacy evaluation for treatment of locally advanced stage III cutaneous squamous cell carcinoma: a 22-cases retrospective analysis.The role of spectrophotometry in the diagnosis of melanoma.Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy.Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-alpha 2b treatmentMetastatic eccrine porocarcinoma: report of a case and review of the literature.Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas.Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction.Clinicopathologic features and surgical management of primary umbilical melanoma: a case series.Resection in the popliteal fossa for metastatic melanomaAssessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy.Collagen sealant patch to reduce lymphatic drainage after lymph node dissectionSuperficial and deep lymph node dissection for stage III cutaneous melanoma: clinical outcome and prognostic factors.Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma.Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma.COX-2 expression positively correlates with PD-L1 expression in human melanoma cells.Locoregional spread of cutaneous melanoma: sonography findings.Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.Electrochemotherapy as "new standard of care" treatment for cutaneous Kaposi's sarcoma.Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South Italy.The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasis.Age as predictor in patients with cutaneous melanoma submitted to sentinel lymph node biopsy.EANM-EORTC general recommendations for sentinel node diagnostics in melanoma.Vemurafenib beyond progression in a patient with metastatic melanoma: a case report.BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma.Number of excised lymph nodes as a quality assurance measure for lymphadenectomy in melanoma.Can high-resolution ultrasound avoid the sentinel lymph-node biopsy procedure in the staging process of patients with stage I-II cutaneous melanoma?Low Levels of Genetic Heterogeneity in Matched Lymph Node Metastases from Patients with Melanoma.Erratum to: Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanomaImmunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanomaMobile hospital rooms to fight melanomaSentinel Node Biopsy in Thin and Thick MelanomaSoluble interleukin-2 receptor in stage I–III melanomaPost-operative complications after completion thyroidectomy for differentiated thyroid cancerSentinel lymph node biopsy in patients with cutaneous melanoma: outcome after 3-year follow-upImpact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanomaRenal cell carcinoma with solitary toe metastasis
P50
Q30497030-FD300F54-F716-4C61-8214-53A0956FDC42Q30875021-90E1BFF1-D2BD-433E-AA3A-FD5B3B4196F1Q33263686-38743D46-A544-4403-B8DD-BD096201E82EQ33604418-1376B71C-752A-4269-B09F-C1EED05E45D6Q33657461-BA697015-7786-4BF8-9ADB-90225DED3690Q33930593-FB8E1B49-743F-49D7-917C-F5DF64D99B1DQ34114136-73A4A5A8-3962-48CD-82AA-2575211C76C7Q34743761-D681EA3B-2768-49A8-ADCC-296084555A0DQ35033377-01951E31-763E-4635-AD8B-5E151FD2B246Q35074715-EDEAEC45-F3C2-498C-A022-5C405606D573Q35496973-2D73BBB9-F75F-43F4-8557-839068013523Q35614030-0E936C8D-3BB7-4AF6-A464-2804DE60075AQ35798996-1FDDEFDD-F5D7-46E7-8F5B-2AE6E353492DQ36541920-748810FC-C640-4007-9108-22FFE88C7BA3Q36648843-B92AADFA-4A89-4475-B53C-F4750A4DABADQ36687470-68690989-4192-479E-8FD1-9B89B95779FEQ37152975-308BB96B-9485-489E-9A01-0ECC58E516D9Q37663388-4A24BBFC-9AF8-4B6C-A7F1-048D132A1315Q37696003-D70CFECF-8CCF-4611-97B0-F5D70032D8DCQ41175351-D9AFC098-B95B-4B48-B94B-580A47317D48Q42266082-53724A27-2CB5-4654-AEF6-05AC96C62DBBQ44665315-7F0D4A66-C7AF-4C15-B076-00E446163011Q44857485-600D685D-64AD-44D1-A354-5E195FC1D981Q45251843-DB2365E4-6B1B-4E75-BA9C-2962A6C25BB9Q47630726-E989DCFE-0CA7-469A-927F-B8837CA2BB83Q48359916-F30C18E0-D7AC-46FE-9CAF-C5BCB53A0409Q48499411-6D160B7F-5728-47F7-B843-19D126CCE485Q51141486-3B995E62-A108-4942-B621-6BEA6047C6D3Q53145031-8E39C3ED-AE2A-4878-9B6B-A7E5BB1BDAC2Q55021616-F266274B-9090-46FD-B402-78E6B16A98EEQ57781468-100528C8-B648-4D04-AD47-CFEB64D09D23Q57781473-499BEDA7-E964-4C55-9DEC-8349451C3081Q57781657-BDEFBCD9-C3EF-4F8D-A416-A1C43507A87EQ59489494-43456EC5-A605-46B6-B078-6D7660548326Q63247800-DEAABDC6-F066-4EC7-84F1-C69BB91FD5E6Q73543827-DED14686-C5D0-488E-9E47-93B7A7FBA887Q79870041-7F4EB041-DE9C-43C4-A4AC-DD7331ED39BBQ80539878-37D7F11F-374A-4FA9-84D3-9F83A6749280Q81835534-362B4CD0-AB38-4E5F-B96F-01FE6AF190F8
P50
description
researcher ORCID ID = 0000-0002-7828-079X
@en
wetenschapper
@nl
name
Corrado Caracò
@ast
Corrado Caracò
@en
Corrado Caracò
@es
Corrado Caracò
@nl
type
label
Corrado Caracò
@ast
Corrado Caracò
@en
Corrado Caracò
@es
Corrado Caracò
@nl
prefLabel
Corrado Caracò
@ast
Corrado Caracò
@en
Corrado Caracò
@es
Corrado Caracò
@nl
P106
P1153
7003820188
P31
P496
0000-0002-7828-079X